AKT1 and metabolic dysfunction-associated steatotic liver disease: In the following sections, we will summarize the role of the PI3K/AKT signaling pathway in hepatic metabolism to elucidate the mechanisms underlying the development and progression of MASLD/MASH (Figures 1, 2).